These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7785852)

  • 1. Antiidiotypic antibodies as functional internal images of enzyme-active sites.
    Friboulet A; Izadyar L; Avalle B; Roseto A; Thomas D
    Ann N Y Acad Sci; 1995 Mar; 750():265-70. PubMed ID: 7785852
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiidiotypic antibodies exhibiting an acetylcholinesterase abzyme activity.
    Joron L; Izadyar L; Friboulet A; Remy MH; Pancino G; Roseto A; Thomas D
    Ann N Y Acad Sci; 1992 Nov; 672():216-23. PubMed ID: 1476371
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoclonal anti-idiotypic antibodies as functional internal images of enzyme active sites: production of a catalytic antibody with a cholinesterase activity.
    Izadyar L; Friboulet A; Remy MH; Roseto A; Thomas D
    Proc Natl Acad Sci U S A; 1993 Oct; 90(19):8876-80. PubMed ID: 8415624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalysis by anti-idiotypic antibodies.
    Avalle B; Friboulet A; Thomas D
    Chem Immunol; 2000; 77():80-8. PubMed ID: 11706707
    [No Abstract]   [Full Text] [Related]  

  • 5. Catalytic antibodies with acetylcholinesterase activity.
    Johnson G; Moore SW
    J Immunol Methods; 2002 Nov; 269(1-2):13-28. PubMed ID: 12379349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antiidiotypic approach to obtaining a proteolytic antibody.
    Smirnov IV; Vorobiev II; Friboulet A; Avalle B; Thomas D; Knorre VD; Gabibov AG; Ponomarenko NA
    Dokl Biochem Biophys; 2008; 420():105-7. PubMed ID: 18680902
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-acetylcholinesterase antibodies display cholinesterase-like activity.
    Johnson G; Moore SW
    Eur J Immunol; 1995 Jan; 25(1):25-9. PubMed ID: 7843238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A structure-activity study of a catalytic antiidiotypic antibody to the human erythrocyte acetylcholinesterase].
    Aleksandrova ES; Koralevski F; Titov MI; Demin AV; Kozyr' AV; Kolesnikov AV; Tramontano A; Paul S; Thomas D; Gabibov AG; Gnuchev NV; Friboulet A
    Bioorg Khim; 2002; 28(2):118-25. PubMed ID: 11962233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A suicide-substrate mechanism for hydrolysis of beta-lactams by an anti-idiotypic catalytic antibody.
    Lefevre S; Debat H; Thomas D; Friboulet A; Avalle B
    FEBS Lett; 2001 Jan; 489(1):25-8. PubMed ID: 11231007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of a novel adhesion-promoting site on acetylcholinesterase using catalytic antiacetylcholinesterase antibodies displaying cholinesterase-like activity.
    Johnson G; Moore SW
    Appl Biochem Biotechnol; 2000; 83(1-3):131-44; discussion 145-53. PubMed ID: 10826955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of a functional scFv fragment of an anti-idiotypic antibody with a beta-lactam hydrolytic activity.
    Padiolleau-Lefèvre S; Débat H; Phichith D; Thomas D; Friboulet A; Avalle B
    Immunol Lett; 2006 Feb; 103(1):39-44. PubMed ID: 16325271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abzyme generation using an anti-idiotypic antibody as the "internal image" of an enzyme active site.
    Friboulet A; Izadyar L; Avalle B; Roseto A; Thomas D
    Appl Biochem Biotechnol; 1994; 47(2-3):229-37; discussion 237-9. PubMed ID: 7944340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalytic mechanism of an abzyme displaying a beta-lactamase-like activity.
    Avalle B; Débat H; Friboulet A; Thomas D
    Appl Biochem Biotechnol; 2000; 83(1-3):163-9; discussion 169-71, 297-313. PubMed ID: 10826957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production and characterization of monoclonal anti-idiotypic antibody exhibiting a catalytic activity similar to carboxypeptidase A.
    Hu R; Xie GY; Zhang X; Guo ZQ; Jin S
    J Biotechnol; 1998 Apr; 61(2):109-15. PubMed ID: 9654744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of pyridoxal 5'-phosphate dependent catalytic antibodies.
    Khomutov RM
    Biochemistry (Mosc); 2002 Oct; 67(10):1085-8. PubMed ID: 12460106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme mimicry by the antiidiotypic antibody approach.
    Kolesnikov AV; Kozyr AV; Alexandrova ES; Koralewski F; Demin AV; Titov MI; Avalle B; Tramontano A; Paul S; Thomas D; Gabibov AG; Friboulet A
    Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13526-31. PubMed ID: 11095704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigations into the development of catalytic activity in anti-acetylcholinesterase idiotypic and anti-idiotypic antibodies.
    Johnson G; Moore SW
    J Mol Recognit; 2009; 22(3):188-96. PubMed ID: 19051205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologically driven chemical engineering of antibodies for catalytic activity.
    Dias S; Jovic F; Renard PY; Taran F; Créminon C; Mioskowski C; Grassi J
    J Immunol Methods; 2002 Nov; 269(1-2):81-98. PubMed ID: 12379354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overpassing an aberrant V(kappa) gene to sequence an anti-idiotypic abzyme with (beta)-lactamase-like activity that could have a linkage with autoimmune diseases.
    Debat H; Avalle B; Chose O; Sarde CO; Friboulet A; Thomas D
    FASEB J; 2001 Mar; 15(3):815-22. PubMed ID: 11259400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of inhibitory monoclonal antibodies. A critical step for producing anti-idiotypic catalytic antibodies.
    Avalle B; Friboulet A; Thomas D
    Ann N Y Acad Sci; 1998 Dec; 864():118-30. PubMed ID: 9928086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.